Auro Laboratories (BOM:530233) Change In Receivables : ₹0.0 Mil (TTM As of Sep. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Auro Laboratories Change In Receivables?

Auro Laboratories's change in receivables for the quarter that ended in Sep. 2024 was ₹0.0 Mil. It means Auro Laboratories's Accounts Receivable stayed the same from Jun. 2024 to Sep. 2024 .

Auro Laboratories's change in receivables for the fiscal year that ended in Mar. 2024 was ₹5.2 Mil. It means Auro Laboratories's Accounts Receivable declined by ₹5.2 Mil from Mar. 2023 to Mar. 2024 .

Auro Laboratories's Accounts Receivable for the quarter that ended in Sep. 2024 was ₹67.8 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Auro Laboratories's Days Sales Outstanding for the three months ended in Sep. 2024 was 199.44.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Auro Laboratories's liquidation value for the three months ended in Sep. 2024 was ₹-233.5 Mil.

Auro Laboratories Change In Receivables Historical Data

The historical data trend for Auro Laboratories's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Auro Laboratories Change In Receivables Chart

Auro Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Receivables

Get a 7-Day Free Trial

30.32

-28.69

-98.24

-5.07

5.25

Auro Laboratories Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Auro Laboratories Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

Auro Laboratories (BOM:530233) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Auro Laboratories's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	67.78	/	31.012	*	91
=	199.44

2. In Ben Graham's calculation of liquidation value, Auro Laboratories's accounts receivable are only considered to be worth 75% of book value:

Auro Laboratories's liquidation value for the quarter that ended in Sep. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	87.214	-	406.598	+	0.75 * 67.78	+	0.5 * 70.12
=	-233.5

Auro Laboratories Change In Receivables Related Terms

Thank you for viewing the detailed overview of Auro Laboratories's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Auro Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Auro Laboratories Ltd (BOM:530233) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

S.K. Ahire Marg, 314, 3rd Floor, T.V. Industrial Estate, Worli, Mumbai, MH, IND, 400 030

Website

http://www.aurolabs.com

Auro Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and selling of pharmaceutical products like Metformin Hydrochloride and Glibenclamide. The pharmaceutical products range offered by the company are anti-diabetic, muscle relaxant, diuretic, iron deficiency anti-fungal, anti-ulcer, iodine supplement, anti-malaria, antacids, anti-inflammatory, specialty chemicals, and others. The company sells its products in India and also exports it to international countries.

Auro Laboratories Headlines

No Headlines